Abbott Laboratories (ABT) R&D In Process (2010 - 2012)

Abbott Laboratories has disclosed R&D In Process across 3 years of filings, most recently posting $28.0 million for Q4 2012.

• R&D In Process for Q4 2012 came in at $28.0 million, down 93.0% year-over-year; the trailing twelve-month figure through Dec 2012 was $188.0 million (down 75.76% YoY), and the FY2012 annual result was $288.0 million, down 57.17% from the prior year.
• R&D In Process came in at $28.0 million for Q4 2012 at Abbott Laboratories, down from $110.0 million in the prior quarter.
• In the past five years, R&D In Process ranged from a high of $400.0 million in Q4 2011 to a low of $28.0 million in Q4 2012.
• The 3-year median for R&D In Process is $100.0 million (2011), against an average of $141.9 million.
• Across the five-year window, R&D In Process surged 67.93% in 2011 and slumped 93.0% in 2012, its largest moves.
• Abbott Laboratories' R&D In Process stood at $238.2 million in 2010, then soared by 67.93% to $400.0 million in 2011, then plunged by 93.0% to $28.0 million in 2012.
• The last three R&D In Process figures came in at $28.0 million (Q4 2012), $110.0 million (Q2 2012), and $50.0 million (Q1 2012), per Business Quant data.